The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Implementation and Validation of Lysosome-specific Tests of GCase Activity in Cell Lines and Human Peripheral Blood
Study Rationale: Glucocerebrosidase (GCase) is an enzyme that is linked to Parkinson’s disease (PD) and is a high value target for disease-modifying treatments. Developing robust methods for...
-
Novel PET Tracer Development Program, 2023Monitoring Glucocerebrosidase Engagement in Parkinson’s Disease
Study Rationale: Glucocerebrosidase is an enzyme that is essential for maintaining healthy lipid metabolism throughout the human body. In Parkinson’s disease (PD), the efficiency of this protein is...
-
Research Grant, 2023Developing Wiring Diagrams of the Brain-Body Connection
Study Rationale: Individuals with Parkinson’s disease (PD) can show a variety of symptoms, including: resting tremors, alterations in directed hand movements, and treatment-induced dyskinesias; loss...
-
Data-Driven Subtyping and Stratification Program, 2023Identifying Proteomic Biomarkers for Monitoring the Progression of Parkinson’s Pathophysiology
Study Rationale: Parkinson’s disease (PD) is often diagnosed at a stage where the disease has progressed significantly, restricting treatment options and limiting the opportunity to understand how the...
-
Circuits & Cellular Targets for PD’s Symptoms, 2023Pathophysiology of Neural Circuits Underlying Pain in Prodromal to Advanced Parkinson’s Disease
Study Rationale: Many people with Parkinson’s disease (PD) suffer from pain that is not managed well by existing therapies. We believe the ineffectiveness of these treatment strategies may be due to a...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Surviving on Borrowed Energy: Using Mitochondrial Transfer to Treat Parkinson’s Disease
Study Rationale: By the time the symptoms of Parkinson’s disease (PD) appear, many of the brain cells that produce the chemical dopamine have already died. This loss of dopamine-making cells leads to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.